Old Point Trust & Financial Services N A’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.93M Sell
19,700
-2,720
-12% -$970K 2.23% 11
2025
Q4
$7.34M Sell
22,420
-251
-1% -$79.6K 2.29% 13
2025
Q3
$6.4M Sell
22,671
-320
-1% -$92.8K 2.07% 16
2025
Q2
$6.42M Sell
22,991
-1,278
-5% -$362K 2.24% 17
2025
Q1
$7.56M Sell
24,269
-185
-0.8% -$54.6K 2.65% 11
2024
Q4
$6.37M Sell
24,454
-405
-2% -$120K 2.24% 16
2024
Q3
$8.01M Sell
24,859
-775
-3% -$254K 2.88% 10
2024
Q2
$8.01M Sell
25,634
-2,050
-7% -$602K 3.11% 8
2024
Q1
$7.87M Sell
27,684
-615
-2% -$180K 2.86% 9
2023
Q4
$8.15M Sell
28,299
-535
-2% -$146K 3.29% 9
2023
Q3
$7.75M Sell
28,834
-30
-0.1% -$7.49K 3.5% 8
2023
Q2
$6.41M Buy
28,864
+5
+0% +$1.16K 2.67% 13
2023
Q1
$6.98M Sell
28,859
-265
-0.9% -$65K 3.05% 12
2022
Q4
$7.65M Sell
29,124
-467
-2% -$125K 3.53% 10
2022
Q3
$6.67M Buy
29,591
+710
+2% +$172K 3.35% 10
2022
Q2
$7.03M Sell
28,881
-1,354
-4% -$332K 3.25% 10
2022
Q1
$7.31M Buy
30,235
+529
+2% +$122K 2.99% 13
2021
Q4
$6.68M Buy
29,706
+530
+2% +$112K 2.69% 13
2021
Q3
$6.2M Sell
29,176
-221
-0.8% -$50.9K 2.77% 13
2021
Q2
$7.17M Buy
29,397
+247
+0.8% +$60.8K 3.16% 10
2021
Q1
$7.25M Buy
29,150
+1,090
+4% +$260K 3.37% 9
2020
Q4
$6.45M Buy
28,060
+280
+1% +$64.6K 3.3% 10
2020
Q3
$7.06M Sell
27,780
-1,824
-6% -$452K 3.88% 7
2020
Q2
$6.98M Buy
29,604
+49
+0.2% +$11.2K 3.83% 6
2020
Q1
$5.99M Sell
29,555
-178
-0.6% -$38.9K 3.76% 7
2019
Q4
$7.17M Sell
29,733
-600
-2% -$132K 3.3% 8
2019
Q3
$5.87M Buy
30,333
+460
+2% +$88.3K 2.86% 12
2019
Q2
$5.5M Buy
29,873
+450
+2% +$80.6K 2.8% 11
2019
Q1
$5.59M Buy
29,423
+315
+1% +$60.2K 2.91% 12
2018
Q4
$5.67M Buy
29,108
+626
+2% +$122K 3.34% 9
2018
Q3
$5.9M Buy
28,482
+575
+2% +$113K 3.05% 11
2018
Q2
$5.15M Buy
27,907
+2,195
+9% +$388K 2.82% 13
2018
Q1
$4.38M Buy
25,712
+1,045
+4% +$192K 2.48% 15
2017
Q4
$4.29M Buy
24,667
+149
+0.6% +$26.4K 2.32% 16
2017
Q3
$4.57M Buy
24,518
+125
+0.5% +$22.1K 2.57% 15
2017
Q2
$4.2M Sell
24,393
-1,400
-5% -$228K 2.44% 14
2017
Q1
$4.23M Buy
25,793
+1,433
+6% +$238K 2.45% 16
2016
Q4
$3.56M Buy
24,360
+835
+4% +$126K 2.13% 18
2016
Q3
$3.92M Hold
23,525
2.42% 15
2016
Q2
$3.58M Sell
23,525
-400
-2% -$62.2K 2.23% 16
2016
Q1
$3.59M Buy
23,925
+875
+4% +$130K 2.25% 17
2015
Q4
$3.74M Sell
23,050
-100
-0.4% -$15.7K 2.43% 15
2015
Q3
$3.2M Sell
23,150
-450
-2% -$70.9K 2.28% 20
2015
Q2
$3.62M Buy
23,600
+25
+0.1% +$4K 2.35% 18
2015
Q1
$3.77M Buy
23,575
+100
+0.4% +$15.7K 2.43% 18
2014
Q4
$3.74M Hold
23,475
2.25% 20
2014
Q3
$3.3M Sell
23,475
-212
-0.9% -$27.7K 1.97% 23
2014
Q2
$2.8M Sell
23,687
-163
-0.7% -$18.9K 1.67% 27
2014
Q1
$2.94M Sell
23,850
-200
-0.8% -$24.3K 1.84% 23
2013
Q4
$2.74M Sell
24,050
-100
-0.4% -$11.4K 1.79% 25
2013
Q3
$2.7M Sell
24,150
-62
-0.3% -$6.72K 1.87% 24
2013
Q2
$2.39M Buy
+24,212
New +$2.51M 1.7% 28

Other funds holding AMGN

Old Point Trust & Financial Services N A's AMGN Position: Q1 2026 in Review

Old Point Trust & Financial Services N A reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $970K and leaving 19,700 shares worth $6.93M. The position accounts for 2.23% of the portfolio, ranked #11.

Old Point Trust & Financial Services N A first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.15M in Q4 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Old Point Trust & Financial Services N A held 19,700 shares of Amgen worth $6.93M as of Q1 2026.
  • Old Point Trust & Financial Services N A sold 2,720 Amgen shares in Q1 2026, an estimated $970K.
  • Amgen made up 2.23% of Old Point Trust & Financial Services N A's portfolio in Q1 2026, its #11 holding.
  • Old Point Trust & Financial Services N A first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Old Point Trust & Financial Services N A's Amgen position peaked at $8.15M in Q4 2023.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Old Point Trust & Financial Services N A's 13F filing for Q1 2026, filed 22 Apr 2026.